Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Endocrine 2Thoracic 1Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Ovarian Neoplasms 37Carcinoma, Non-Small-Cell Lung 23Uterine Cervical Neoplasms 22Melanoma 22Carcinoma, Renal Cell 18Endometrial Neoplasms 16Colorectal Neoplasms 15Carcinoma, Transitional Cell 15Triple Negative Breast Neoplasms 13Stomach Neoplasms 13Fallopian Tube Neoplasms 12Squamous Cell Carcinoma of Head and Neck 10Carcinoma, Hepatocellular 10Pancreatic Neoplasms 9Breast Neoplasms 9Head and Neck Neoplasms 8Carcinoma, Ovarian Epithelial 8Carcinoma, Merkel Cell 8Small Cell Lung Carcinoma 7Prostatic Neoplasms 7Neoplasms 7Neoplasm Metastasis 7Lung Neoplasms 6Esophageal Neoplasms 6Cholangiocarcinoma 6Urinary Bladder Neoplasms 5Mesothelioma 5Lymphoma 4Carcinosarcoma 4Vulvar Neoplasms 3

Interventions

Trastuzumab 2trametinib 1tipifarnib 1sargramostim 1entrectinib 1dabrafenib 1cobimetinib 1alectinib 1aldesleukin 1Vemurafenib 1Taxes 1Ritonavir 1Radiotherapy 1Paclitaxel 1Nivolumab 1Interleukin-12 Subunit p35 1Interleukin-12 1Indinavir 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thyroid Cancer, Papillary × Nivolumab × Gynecologic × Clear all
NCT04731467 2024-12-27

A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors

Purple Biotech Ltd.

Phase 1/2 Completed
79 enrolled
DermatologicEndocrineGastrointestinalGynecologicHead & NeckThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡